A systematic comparison of single-cell transcriptome profiles between EGFR-WT and EGFR-MT tumors can reveal immune cell subsets that differentially accumulate between groups of molecular subtypes in NSCLC tumors, some of which may provide important clues regarding their difference in clinical outcomes. Here, EGFR is linked to non-small cell lung carcinoma.